Cited by 139Advanced MRI Techniques and ApplicationsLanthanide and Transition Metal ComplexesCardiac Imaging and Diagnostics

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

MR angiography with blood pool contrast agents

Bremerich, Jens, Bilecen, Deniz, Reimer, Peter·2007·European Radiology

DOI 10.1007/s00330-007-0712-0

Open this paper in CoChat — free account

Abstract

Contrast-enhanced magnetic resonance angiography (CE-MRA) with standard extracellular contrast material is well established for vascular imaging. Recently, the first blood pool contrast agent (BPA) has become clinically available. This paper reviews characteristics and classification of BPA as well as first clinical experience in various vascular territories. BPAs comprise gadolinium-based compounds, synthetic compounds, and ultrasmall superparamagnetic iron-oxide (USPIO) particles. Such BPAs are retained in blood with a prolonged time-window of enhancement as compared to extracellular gadolinium chelates. Promising results from USPIO at first-pass and steady-state angiography have been published, but no USPIO is approved yet. Gadofosveset is the first clinically approved BPA. After bolus injection, gadofosveset binds noncovalently to serum-albumine, thus enhancing relaxivity. First published results from carotid, coronary, renal, and peripheral angiography are encouraging; particularly helpful is prolonged enhancement during steady state. More BPAs have been clinically evaluated, but no approval has been granted. Bolus-injectable BPAs allow for first-pass CE-MRA similar to standard extracellular contrast media, but with higher relaxivity, allowing lower doses and reduced injection rates. An additional feature of BPA is the steady-state phase with a broad time window enabling high-resolution angiography or double-gated angiography of coronary arteries to compensate for the complex motion pattern.

Integrity signals

Registry

Crossref · 10.1007/s00330-007-0712-0

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths
Rohrer, M., Bauer, H., Mintorovitch, J., Requardt, M., & Weinmann, H. (2005) · Investigative Radiology · doi:10.1097/01.rli.0000184756.66360.d3 · Cited by 1,681
Molecular Imaging
Weissleder, R., & Mahmood, U. (2001) · Radiology · doi:10.1148/radiology.219.2.r01ma19316 · Cited by 1,315
Nephrogenic Systemic Fibrosis: Risk Factors and Incidence Estimation
Sadowski, E. A., Bennett, L. K., Chan, M. R., Wentland, A. L., Garrett, A. L., Garrett, R. W., & Djamali, A. (2007) · Radiology · doi:10.1148/radiol.2431062144 · Cited by 1,011
A Preliminary Report Comparing Magnetic Resonance Coronary Angiography with Conventional Angiography
Manning, W. J., Li, W., & Edelman, R. R. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303253281202 · Cited by 547
MS-325: albumin-targeted contrast agent for MR angiography.
Lauffer, R. B., Parmelee, D. J., Dunham, S. U., Ouellet, H. S., Dolan, R. P., Witte, S., McMurry, T. J., & Walovitch, R. C. (1998) · Radiology · doi:10.1148/radiology.207.2.9577506 · Cited by 457
Functional tumor imaging with dynamic contrast‐enhanced magnetic resonance imaging
Choyke, P. L., Dwyer, A. J., & Knopp, M. V. (2003) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10304 · Cited by 440
Diagnostic Tests for Renal Artery Stenosis in Patients Suspected of Having Renovascular Hypertension
Vasbinder, G. B. C., Nelemans, P. J., Kessels, A. G. H., Kroon, A. A., de Leeuw, P. W., & van Engelshoven, J. M. A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00009 · Cited by 380
Accuracy of Computed Tomographic Angiography and Magnetic Resonance Angiography for Diagnosing Renal Artery Stenosis
Vasbinder, G. B. C., Nelemans, P. J., Kessels, A. G. H., Kroon, A. A., Maki, J. H., Leiner, T., Beek, F. J. A., Korst, M. B. J. M., Flobbe, K., de Haan, M. W., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-9-200411020-00007 · Cited by 365
Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide
Thomsen, H. S. (2006) · European Radiology · doi:10.1007/s00330-006-0495-8 · Cited by 352
Albumin Labeled with Gd-DTPA
Ogan, M. D., Schmiedl, U. P., Moseley, M. E., Grodd, W., Paajanen, H., & Brasch, R. C. (1987) · Investigative Radiology · doi:10.1097/00004424-198708000-00008 · Cited by 275

Show all 43 references

Research works printed but not linked: 1

Cavagna FM, Zheng J, Lorusso V, Maggioni F, Li D, Finn PJ (1999) New proton binding Gd chelate with high vascular containment for MR coronary angiography. J Cardio Magn Reson 1:387–388

Sorted by citations

Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
Dadfar, S. M., Roemhild, K., Drude, N. I., von Stillfried, S., Knüchel, R., Kiessling, F., & Lammers, T. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.005 · Cited by 1,181
Large-Scale Synthesis of Uniform and Extremely Small-Sized Iron Oxide Nanoparticles for High-Resolution T 1 Magnetic Resonance Imaging Contrast Agents
Kim, B. H., Lee, N., Kim, H., An, K., Park, Y. I., Choi, Y., Shin, K., Lee, Y., Kwon, S. G., Na, H. B., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja203340u · Cited by 957
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine
Zhang, X., Xu, X., Bertrand, N., Pridgen, E. M., Swami, A., & Farokhzad, O. C. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.005 · Cited by 494
25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives
Lohrke, J., Frenzel, T., Endrikat, J., Caseiro‐Alves, F., Grist, T. M., Law, M., Lee, J. M., Leiner, T., Li, K.-C., Nikolaou, K., et al. (2016) · Advances in Therapy · doi:10.1007/s12325-015-0275-4 · Cited by 436
Emerging applications for ferumoxytol as a contrast agent in MRI
Bashir, M. R., Bhatti, L., Marin, D., & Nelson, R. C. (2014) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24691 · Cited by 373
Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications
Jin, R., Lin, B., Li, D., & Ai, H. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.08.002 · Cited by 305
Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
Neuwelt, E. A., Hamilton, B. E., Varallyay, C. G., Rooney, W. R., Edelman, R. D., Jacobs, P. M., & Watnick, S. G. (2009) · Kidney International · doi:10.1038/ki.2008.496 · Cited by 267
Therapeutic Nanoparticles in Clinics and Under Clinical Evaluation
Schütz, C. A., Juillerat‐Jeanneret, L., Mueller, H., Lynch, I., & Riediker, M. (2013) · Nanomedicine · doi:10.2217/nnm.13.8 · Cited by 241
Enabling individualized therapy through nanotechnology
Sakamoto, J. H., van de Ven, A. L., Godin, B., Blanco, E., Serda, R. E., Grattoni, A., Žiemys, A., Bouamrani, A., Hu, Y., Ranganathan, S. I., et al. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2009.12.011 · Cited by 234
Ultrasmall Ferrite Nanoparticles Synthesized via Dynamic Simultaneous Thermal Decomposition for High-Performance and Multifunctional T 1 Magnetic Resonance Imaging Contrast Agent
Zhang, H., Li, L., Liu, X., Jiao, J., Ng, C.-T., Yi, J. B., Luo, Y., Bay, B., Zhao, L., Peng, M., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b07684 · Cited by 227
Safety and technique of ferumoxytol administration for MRI
Vasanawala, S. S., Nguyen, K., Hope, M. D., Bridges, M. D., Hope, T. A., Reeder, S. B., & Bashir, M. R. (2016) · Magnetic Resonance in Medicine · doi:10.1002/mrm.26151 · Cited by 210
The effect of carboxydextran-coated superparamagnetic iron oxide nanoparticles on c-Jun N-terminal kinase-mediated apoptosis in human macrophages
Lunov, O., Syrovets, T., Büchele, B., Jiang, X., Röcker, C., Tron, K., Nienhaus, G. U., Walther, P., Mailänder, V., Landfester, K., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.023 · Cited by 157
Synthesis and design of biologically inspired biocompatible iron oxide nanoparticles for biomedical applications
Demirer, G. S., Okur, A. C., & Kızılel, S. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00931f · Cited by 147
Iron Oxide Particles for Atheroma Imaging
Tang, T. Y., Müller, K. H., Graves, M. J., Li, Z. Y., Walsh, S. R., Young, V. E. L., Sadat, U., Howarth, S. P. S., & Gillard, J. H. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.165514 · Cited by 137
Nanoparticles with targeting, triggered release, and imaging functionality for cancer applications
Loomis, K. H., McNeeley, K. M., & Bellamkonda, R. V. (2010) · Soft Matter · doi:10.1039/c0sm00534g · Cited by 133
New Dual Mode Gadolinium Nanoparticle Contrast Agent for Magnetic Resonance Imaging
Ghaghada, K. B., Ravoori, M. K., Sabapathy, D. G., Bankson, J. A., Kundra, V., & Annapragada, A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007628 · Cited by 114
Oxygen Vacancy Enables Markedly Enhanced Magnetic Resonance Imaging-Guided Photothermal Therapy of a Gd3+-Doped Contrast Agent
Ni, D., Zhang, J., Wang, J., Hu, P., Jin, Y., Tang, Z., Yao, Z., Bu, W., & Shi, J. (2017) · ACS Nano · doi:10.1021/acsnano.7b01297 · Cited by 106
Encapsulation of Superparamagnetic Nanoparticles Into Red Blood Cells as New Carriers of MRI Contrast Agents
Antonelli, A., Sfara, C., Manuali, E., Bruce, I. J., & Magnani, M. (2011) · Nanomedicine · doi:10.2217/nnm.10.163 · Cited by 86
A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements
Giannakou, C., Park, M. V. D. Z., de Jong, W., Loveren, H. V., Vandebriel, R. J., & Geertsma, R. E. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s102385 · Cited by 79
Contemporary Imaging of Cerebral Arteriovenous Malformations
Tranvinh, E., Heit, J. J., Hacein‐Bey, L., Provenzale, J., & Wintermark, M. (2017) · American Journal of Roentgenology · doi:10.2214/ajr.16.17306 · Cited by 77
In vivo quantification of contrast agent concentration using the induced magnetic field for time‐resolved arterial input function measurement with MRI
de Rochefort, L., Nguyen, T. D., Brown, R., Spincemaille, P., Choi, G. H., Weinsaft, J. W., Prince, M. R., & Wang, Y. (2008) · Medical Physics · doi:10.1118/1.3002309 · Cited by 75
Prolonged in vivo circulation time by zwitterionic modification of magnetite nanoparticles for blood pool contrast agents
Xiao, W., Lin, J., Li, M., Ma, Y., Chen, Y., Zhang, C., Li, D., & Gu, H. (2012) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.501 · Cited by 69
MR Angiography of the Lower Extremities
Ersoy, H., & Rybicki, F. J. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.07.2223 · Cited by 65
High-resolution, whole-body vascular imaging with ferumoxytol as an alternative to gadolinium agents in a pediatric chronic kidney disease cohort
Nayak, A. B., Luhar, A., Hanudel, M. R., Gales, B., Hall, T. R., Finn, J. P., Salusky, I. B., & Zaritsky, J. J. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-2953-x · Cited by 62
A multiple gadolinium complex decorated fullerene as a highly sensitive T 1 contrast agent
Wang, L., Zhu, X., Tang, X., Wu, C., Zhou, Z., Sun, C., Deng, S., Ai, H., & Gao, J. (2015) · Chemical Communications · doi:10.1039/c5cc00285k · Cited by 63
Ferumoxytol as an off-label contrast agent in body 3T MR angiography: a pilot study in children
Ruangwattanapaisarn, N., Hsiao, A., & Vasanawala, S. S. (2014) · Pediatric Radiology · doi:10.1007/s00247-014-3226-3 · Cited by 61
Dual MRI T1 and T2(⁎) contrast with size-controlled iron oxide nanoparticles
Jung, H., Park, B., Lee, C., Cho, J., Suh, J., Park, J., Kim, Y., Kim, J., Cho, G., & Cho, H. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.05.003 · Cited by 58
Renal Transplant Imaging Using Magnetic Resonance Angiography With a Nonnephrotoxic Contrast Agent
Bashir, M. R., Jaffe, T. A., Brennan, T. V., Patel, U. D., & Ellis, M. J. (2013) · Transplantation · doi:10.1097/tp.0b013e318295464c · Cited by 54
MR Vascular Fingerprinting in Stroke and Brain Tumors Models
Lemasson, B., Pannetier, N. A., Coquery, N., Boisserand, L. S. B., Collomb, N., Schuff, N. W., Moseley, M. E., Zaharchuk, G., Barbier, E., & Christen, T. (2016) · Scientific Reports · doi:10.1038/srep37071 · Cited by 48
Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability
Metz, S., Beer, A. J., Settles, M., Pelisek, J., Botnar, R. M., Rummeny, E. J., & Heider, P. (2010) · International journal of cardiac imaging · doi:10.1007/s10554-010-9736-7 · Cited by 43
T1‐weighted ultrashort echo time method for positive contrast imaging of magnetic nanoparticles and cancer cells bound with the targeted nanoparticles
Zhang, L., Zhong, X., Wang, L., Chen, H., Wang, Y. A., Yeh, J., Yang, L. P. H., & Mao, H. Z. (2010) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22412 · Cited by 43
Detection of vascularity in wrist tenosynovitis: power doppler ultrasound compared with contrast-enhanced grey-scale ultrasound
Klauser, A. S., Franz, M., Arora, R. R., Feuchtner, G. M., Gruber, J., Schirmer, M., Jaschke, W. R., & Gabl, M. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3185 · Cited by 42
Ultra-large-scale production of ultrasmall superparamagnetic iron oxide nanoparticles for T 1 -weighted MRI
Rui, Y., Liang, B., Hu, F., Xu, J., Peng, Y., Yin, P., Duan, Y., Zhang, C., & Gu, H. (2016) · RSC Advances · doi:10.1039/c6ra00347h · Cited by 42
Gd Complexes of Macrocyclic Diethylenetriaminepentaacetic Acid (DTPA) Biphenyl-2,2′-bisamides as Strong Blood-Pool Magnetic Resonance Imaging Contrast Agents
Jung, K., Kim, H., Lee, G. H., Kang, D.-S., Park, J. A., Kim, K. M., Chang, Y., & Kim, T. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2002052 · Cited by 38
Ferumoxytol-enhanced magnetic resonance angiography for the assessment of potential kidney transplant recipients
Stoumpos, S., Hennessy, M., Vesey, A. T., Radjenovic, A., Kasthuri, R. S., Kingsmore, D. B., Mark, P. B., & Roditi, G. (2017) · European Radiology · doi:10.1007/s00330-017-4934-5 · Cited by 38
Microwave-assisted synthesis of magnetite nanoparticles for MR blood pool contrast agents
Xiao, W., Gu, H., Li, D., Chen, D., Deng, X., Jiao, Z., & Lin, J. (2011) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2011.08.029 · Cited by 38
Design of ProCAs (Protein‐Based Gd3+ MRI Contrast Agents) with High Dose Efficiency and Capability for Molecular Imaging of Cancer Biomarkers
Xue, S., Qiao, J., Jiang, J., Hubbard, K., White, N. O., Wei, L., Li, S., Liu, Z., & Yang, J. J. (2014) · Medicinal Research Reviews · doi:10.1002/med.21313 · Cited by 37
Diagnostic accuracy of contrast-enhanced MR angiography in severe carotid stenosis: meta-analysis with metaregression of different techniques
Menke, J. (2009) · European Radiology · doi:10.1007/s00330-009-1403-9 · Cited by 37
Ferumoxytol-enhanced MR Angiography for Vascular Access Mapping before Transcatheter Aortic Valve Replacement in Patients with Renal Impairment: A Step Toward Patient-specific Care
Nguyen, K., Moriarty, J. M., Plotnik, A. N., Aksoy, O., Yoshida, T., Shemin, R. J., Suh, W., & Finn, J. P. (2017) · Radiology · doi:10.1148/radiol.2017162899 · Cited by 35
Overview of the current concepts in the management of arteriovenous malformations of the brain
Unnithan, A. K. A. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2019-137202 · Cited by 34
Ferumoxytol magnetic resonance angiography: a dose-finding study in patients with chronic kidney disease
Stoumpos, S., Hennessy, M., Vesey, A. T., Radjenovic, A., Kasthuri, R. S., Kingsmore, D. B., Mark, P. B., & Roditi, G. (2019) · European Radiology · doi:10.1007/s00330-019-06137-4 · Cited by 33
Evaluating blood–brain barrier permeability in a rat model of type 2 diabetes
Qiao, J., Lawson, C. M., Rentrup, K. F., Kulkarni, P. P., & Ferris, C. F. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02428-3 · Cited by 33
The art of attraction: applications of multifunctional magnetic nanomaterials for malignant glioma
Wegscheid, M. L., Morshed, R. A., Cheng, Y., & Lesniak, M. S. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.912629 · Cited by 30
Contrast-enhanced magnetic resonance venography in pediatric patients with chronic kidney disease: initial experience with ferumoxytol
Luhar, A., Khan, S. N., Finn, J. P., Ghahremani, S., Griggs, R., Zaritsky, J. J., Salusky, I. B., & Hall, T. R. (2016) · Pediatric Radiology · doi:10.1007/s00247-016-3605-z · Cited by 29
Contrast-enhanced peripheral MRA: technique and contrast agents
Nielsen, Y. W., & Thomsen, H. S. (2012) · Acta Radiologica · doi:10.1258/ar.2012.120008 · Cited by 29
Progress in atherosclerotic plaque imaging
Soloperto, G. (2012) · World Journal of Radiology · doi:10.4329/wjr.v4.i7.353 · Cited by 28
Imaging Modalities to Identity Inflammation in an Atherosclerotic Plaque
Goel, S., Miller, A., Agarwal, C., Zakin, E., Acholonu, M., Gidwani, U. K., Sharma, A., Kulbak, G., Shani, J., & Chen, O. (2015) · Radiology Research and Practice · doi:10.1155/2015/410967 · Cited by 28
Binding of a dimeric manganese porphyrin to serum albumin: towards a gadolinium-free blood-pool T 1 MRI contrast agent
Cheng, W., Ganesh, T., Martínez, F. M., Lam, J. W. Y., Yoon, H., Macgregor, R. B., Scholl, T. J., Cheng, H. M., & Zhang, X. (2014) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-013-1073-6 · Cited by 27
First Magnetic Resonance Imaging-Guided Aortic Stenting and Cava Filter Placement Using a Polyetheretherketone-Based Magnetic Resonance Imaging-Compatible Guidewire in Swine: Proof of Concept
Kos, S., Huegli, R. W., Hofmann, E., Quick, H. H., Kuehl, H., Aker, S., Kaiser, G. M., Borm, P. J. A., Jacob, A. L., & Bilecen, D. (2008) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-008-9483-5 · Cited by 26
Self-citation
Red Blood Cell Membrane-Coated Ultrasmall NaGdF4 Nanoprobes for High-Resolution 3D Magnetic Resonance Angiography
He, F., Zhu, L., Zhou, X., Zhang, P., Cheng, J., Qiao, Y., Feng, Y., Yue, S., Xu, M., Guan, J., et al. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c03530 · Cited by 26
Gd Complexes of DO3A-(Biphenyl-2,2′-bisamides) Conjugates as MRI Blood-Pool Contrast Agents
Jung, K., Kim, H., Park, J. A., Nam, K. S., Lee, G. H., Chang, Y., & Kim, T. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300223b · Cited by 25
Optimization of micelle-encapsulated extremely small sized iron oxide nanoparticles as a T1 contrast imaging agent: biodistribution and safety profile
Suh, M., Park, J. Y., Ko, G. B., Kim, J. Y., Hwang, D. W., Rees, L., Conway, G. E., Doak, S. H., Kang, H., Lee, N., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02699-8 · Cited by 24
The capability of detecting small vessels beyond the conventional MRI sensitivity using iron‐based contrast agent enhanced susceptibility weighted imaging
Wang, H., Jiang, Q., Shen, Y., Zhang, L., Haacke, E. M., Ge, Y., Qi, S., & Hu, J. (2020) · NMR in Biomedicine · doi:10.1002/nbm.4256 · Cited by 22
MR-compatible polyetheretherketone-based guide wire assisting MR-guided stenting of iliac and supraaortic arteries in swine: Feasibility study
Kos, S., Huegli, R. W., Hofmann, E., Quick, H. H., Kuehl, H., Aker, S., Kaiser, G. M., Borm, P. J. A., Jacob, A. L., & Bilecen, D. (2009) · Minimally Invasive Therapy & Allied Technologies · doi:10.1080/13645700902921971 · Cited by 22
Self-citation
Targeted Nanotheranostics: Integration of Preclinical MRI and CT in the Molecular Imaging and Therapy of Advanced Diseases
Bonlawar, J., Setia, A., Challa, R. R., Vallamkonda, B., Mehata, A. K., Vaishali, Viswanadh, M. K., & Muthu, M. S. (2024) · Nanotheranostics · doi:10.7150/ntno.95791 · Cited by 23
Abdominopelvic and Lower Extremity Deep Venous Thrombosis: Evaluation With Contrast-Enhanced MR Venography With a Blood-Pool Agent
Huang, S. Y., Kim, C., Miller, M. J., Gupta, R. T., Lessne, M. L., Horvath, J. J., Boll, D. T., Evans, P. D., Befera, N. T., Krishnan, P., et al. (2013) · American Journal of Roentgenology · doi:10.2214/ajr.12.9611 · Cited by 21
Pulmonary MR Angiography Techniques and Applications
Hecht, E. M., & Rosenkrantz, A. B. (2009) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2009.01.001 · Cited by 21
Gd-complexes of macrocyclic DTPA conjugates of 1,1′-bis(amino)ferrocenes as high relaxivity MRI blood-pool contrast agents (BPCAs)
Kim, H., Park, J. A., Kim, K. M., Sk, N., Kang, D.-S., Lee, J., Chang, Y., & Kim, T. (2010) · Chemical Communications · doi:10.1039/c0cc03145c · Cited by 20
Whole-Heart Coronary Magnetic Resonance Angiography at 1.5 Tesla
Wagner, M., Rösler, R., Lembcke, A. E., Butler, C., Dewey, M., Laule, M., Huppertz, A., Schwenke, C., Warmuth, C., Rief, M., et al. (2010) · Investigative Radiology · doi:10.1097/rli.0b013e3181fac6ef · Cited by 20
Gadofosveset-enhanced MR angiography of the pedal arteries in patients with diabetes mellitus and comparison with selective intraarterial DSA
Röhrl, B., Kunz, R. P., Oberholzer, K., Pitton, M. B., Neufang, A., Dueber, C., & Kreitner, K. (2009) · European Radiology · doi:10.1007/s00330-009-1501-8 · Cited by 20
A Comparison between Gadofosveset Trisodium and Gadobenate Dimeglumine for Steady State MRA of the Thoracic Vasculature
Camren, G. P., Wilson, G. J., Bamra, V. R., Nguyen, K. Q., Hippe, D. S., & Maki, J. H. (2014) · BioMed Research International · doi:10.1155/2014/625614 · Cited by 19
MR Angiographic Follow-Up of Intracranial Aneurysms Treated with Detachable Coils: Evaluation of a Blood-Pool Contrast Medium
Kau, T., Gasser, J., Celedin, S., Rabitsch, E., Eicher, W., Uhl, E., & Hausegger, K. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1622 · Cited by 19
MR Angiography of Collateral Arteries in a Hind Limb Ischemia Model: Comparison between Blood Pool Agent Gadomer and Small Contrast Agent Gd-DTPA
Jaspers, K., Versluis, B., Leiner, T., Dijkstra, P., Oostendorp, M., van Golde, J. C., Post, M. J., & Backes, W. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016159 · Cited by 18
High relaxivity Gd3+-based organic nanoparticles for efficient magnetic resonance angiography
Liu, Z., Zhao, M., Wang, H., Fu, Z., Gao, H., Peng, W., Ni, D., Tang, W., & Gu, Y. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01363-3 · Cited by 18
Quantitative Imaging of Blood-Brain Barrier Permeability Following Repetitive Mild Head Impacts
Leaston, J., Qiao, J., Harding, I. C., Kulkarni, P., Gharagouzloo, C. A., Ebong, E. E., & Ferris, C. F. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.729464 · Cited by 18
Intravascular contrast agents in diagnostic applications: Use of red blood cells to improve the lifespan and efficacy of blood pool contrast agents
Antonelli, A., Sfara, C., & Magnani, M. (2017) · Nano Research · doi:10.1007/s12274-016-1342-0 · Cited by 17
Positive contrast high-resolution 3D-cine imaging of the cardiovascular system in small animals using a UTE sequence and iron nanoparticles at 4.7, 7 and 9.4 T
Trotier, A. J., Lefrançois, W., Renterghem, K. V., Franconi, J., Thiaudière, E., & Miraux, S. (2015) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-015-0167-4 · Cited by 15
Pedal Angiography in Peripheral Arterial Occlusive Disease: First-Pass IV Contrast-Enhanced MR Angiography with Blood Pool Contrast Medium Versus Intraarterial Digital Subtraction Angiography
Kos, S., Reisinger, C., Aschwanden, M., Bongartz, G. M., Jacob, A. L., & Bilecen, D. (2009) · American Journal of Roentgenology · doi:10.2214/ajr.08.1384 · Cited by 16
Self-citation
Gadofosveset‐based biomarker of tissue albumin concentration: Technical validation in vitro and feasibility in vivo
Richardson, O., Bane, O., Scott, M. L. J., Tanner, S. F., Waterton, J. C., Sourbron, S. P., Carroll, T. J., & Buckley, D. L. (2014) · Magnetic Resonance in Medicine · doi:10.1002/mrm.25128 · Cited by 15
Diagnosis of Popliteal Venous Entrapment Syndrome by Magnetic Resonance Imaging Using Blood-Pool Contrast Agents
Beitzke, D., Wolf, F., Jülg, G., Lämmer, J., & Loewe, C. (2009) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-009-9702-8 · Cited by 15
Gadofosveset trisodium-enhanced magnetic resonance angiography of the left atrium—A feasibility study
Wagner, M., Rief, M., Asbach, P., VOGTMANN, T., Huppertz, A., Beling, M., Butler, C., Laule, M., Warmuth, C., Taupitz, M., et al. (2009) · European Journal of Radiology · doi:10.1016/j.ejrad.2009.04.052 · Cited by 15
4D flow image quality with blood pool contrast: a comparison of gadofosveset trisodium and ferumoxytol
Mukai, K., Burris, N. S., Mahadevan, V. S., Foster, E., Ordovas, K. G., & Hope, M. D. (2017) · International journal of cardiac imaging · doi:10.1007/s10554-017-1224-x · Cited by 14
Contrast-Enhanced Magnetic Resonance Angiography
Peldschus, K., Hamdorf, M., Robert, P., Port, M., Graessner, J., Adam, G., & Herborn, C. U. (2008) · Investigative Radiology · doi:10.1097/rli.0b013e3181852158 · Cited by 14
A facile synthetic approach to a biodegradable polydisulfide MRI contrast agent
Cheng, W., Rajendran, R., Ren, W., Gu, L., Zhang, Y., Chuang, K., & Liu, Y. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb00413b · Cited by 13
Extracardiac applications of MR blood pool contrast agent in children
Farmakis, S. G., & Khanna, G. (2014) · Pediatric Radiology · doi:10.1007/s00247-014-3167-x · Cited by 12
Amorphous Albumin Gadolinium-Based Nanoparticles for Ultrahigh-Resolution Magnetic Resonance Angiography
Liu, C., Liu, X., Wei, Z., Chang, Z., Bai, Y., Zeng, P., Cao, Q., Tie, C., Lei, Z., Sun, P., et al. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c16391 · Cited by 12
A High Relaxivity Magnetic Resonance Imaging Contrast Agent Targeted to Serum Albumin
Dumas, S., Troughton, J. S., Cloutier, N. J., Chasse, J. M., McMurry, T. J., & Caravan, P. D. (2008) · Australian Journal of Chemistry · doi:10.1071/ch08164 · Cited by 12
Use of blood pool agents with steady‐state MRI to assess the vascular system
Thakor, A. S., Chung, J., Patel, P. A., Chan, A., Ahmed, A. M., McNeil, G., Liu, D. M., Forster, B. B., & Klass, D. (2017) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25636 · Cited by 12
Impact of the chain length on the biodistribution profiles of PEGylated iron oxide nanoparticles: a multimodal imaging study
Stanicki, D., Larbanoix, L., Boutry, S., Vangijzegem, T., Ternad, I., Garifo, S., Müller, R. N., & Laurent, S. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00573a · Cited by 14
Overcoming the low relaxivity of gadofosveset at high field with spin locking
Richardson, O., Scott, M. L. J., Tanner, S. F., Waterton, J. C., & Buckley, D. L. (2011) · Magnetic Resonance in Medicine · doi:10.1002/mrm.23316 · Cited by 11
Comprehensive MRA of the lower limbs including high-resolution extended-phase infra-inguinal imaging with gadobenate dimeglumine: Initial experience with inter-individual comparison to the blood-pool contrast agent gadofosveset trisodium
Christie, A., Chandramohan, S., & Roditi, G. (2012) · Clinical Radiology · doi:10.1016/j.crad.2012.05.017 · Cited by 11
Preoperative mapping of arterial spinal supply using 3.0-T MR angiography with an intravasal contrast medium and high-spatial-resolution steady-state
Mordasini, P., El‐Koussy, M., Schmidli, J., Bonél, H., Ith, M., Gralla, J., Schroth, G., & Hoppe, H. (2011) · European Journal of Radiology · doi:10.1016/j.ejrad.2011.02.025 · Cited by 11
Vascular Repair by Grafting Based on Magnetic Nanoparticles
Liu, X., Wang, N., Liu, X., Deng, R., Kang, R., & Xie, L. Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071433 · Cited by 10
Improved characterization of popliteal aneurysms using gadofosveset-enhanced equilibrium phase magnetic resonance angiography
Galizia, M. S., Ward, E. V. M., Rodríguez, H. E., Collins, J. D., & Carr, J. (2013) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2012.09.018 · Cited by 10
Magnetic Core-Shell Nanoparticles for Biomedical Applications
Mandal, S., & Chaudhuri, K. (2017) · Springer eBooks · doi:10.1007/978-3-319-52087-2_12 · Cited by 10
Comparison of blood pool and extracellular gadolinium chelate for functional MR evaluation of vascular thoracic outlet syndrome
Lim, R., Bruno, M. T., Rosenkrantz, A. B., Kim, D. C., Mulholland, T., Kwon, J., Palfrey, A., & Ogedegbe, O. (2014) · European Journal of Radiology · doi:10.1016/j.ejrad.2014.04.018 · Cited by 9
Magnetic resonance angiography imaging of pulmonary embolism using agents with blood pool properties as an alternative to computed tomography to avoid radiation exposure
Pressacco, J., Papas, K., Lambert, J., Finn, J. P., Chauny, J., Desjardins, A., Irislimane, Y., Toporowicz, K., Lanthier, C., Samson, P., et al. (2019) · European Journal of Radiology · doi:10.1016/j.ejrad.2019.02.007 · Cited by 9
Ferumoxytol-enhanced MR Venography of the Central Veins of the Thorax for the Evaluation of Stenosis and Occlusion in Patients with Renal Impairment
Gallo, C. J. R., Mammarappallil, J. G., Johnson, D. Y., Chalian, H., Ronald, J., Bashir, M. R., & Kim, C. (2020) · Radiology Cardiothoracic Imaging · doi:10.1148/ryct.2020200339 · Cited by 9
How Different Albumin-Binders Drive Probe Distribution of Fluorescent RGD Mimetics
Höltke, C., Alsibai, W., Grewer, M., Stölting, M., Geyer, C., Eisenblätter, M., Wildgruber, M., & Helfen, A. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.689850 · Cited by 9
Whole-body MR angiography in patients with peripheral arterial disease.
Nielsen, Y. W. (2010) · PubMed · Cited by 8
Synthesis and characterization of new low‐molecular‐weight lysine‐conjugated Gd‐DTPA contrast agents
Laurent, S., Burtéa, C., Elst, L. V., & Müller, R. N. (2010) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.422 · Cited by 8
Contrast-Enhanced Magnetic Resonance Angiography in Rabbits
Kinner, S., Maderwald, S., Parohl, N., Albert, J., Corot, C., Robert, P., Barkhausen, J., & VOGT, F. M. (2011) · Investigative Radiology · doi:10.1097/rli.0b013e31821ae21f · Cited by 8
An advanced micelle-based biodegradable HPMA polymer-gadolinium contrast agent for MR imaging of murine vasculatures and tumors
Li, H., Luo, Q., Zhu, H., Li, Z., Wang, X., Roberts, N., Zhang, H., Gong, Q., Gu, Z., & Luo, K. (2020) · Polymer Chemistry · doi:10.1039/d0py01133a · Cited by 8
Rapid MR venography in children using a blood pool contrast agent and multi-station fat-water-separated volumetric imaging
Ghanouni, P., Walters, S., & Vasanawala, S. S. (2011) · Pediatric Radiology · doi:10.1007/s00247-011-2254-5 · Cited by 5
Implementation of Nanoparticles in Cancer Therapy
Bayır, E., Bilgi, E., & Şendemir, A. (2014) · Advances in chemical and materials engineering book series · doi:10.4018/978-1-4666-5824-0.ch018 · Cited by 5
Contrast‐enhanced magnetic resonance angiography of the peripheral arteries: Technique, tips, pitfalls and problems
Welman, C. J., Harrison, C., & Low, R. S.-T. (2013) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/1754-9485.12027 · Cited by 5
Gadofosveset injection for magnetic resonance angiography
Chiribiri, A., Morton, G., & Nagel, E. C. (2010) · Imaging in Medicine · doi:10.2217/iim.10.39 · Cited by 4
Contrast Agents in Radiology
von Tengg‐Kobligk, H., Mehndiratta, A., & Giesel, F. L. (2013) · Springer eBooks · doi:10.1007/978-1-84882-710-3_15 · Cited by 4
Peripheral MRA with k-space Segmentation and Blood-Pool Contrast Agent
Kinner, S., Zenge, M. O., Heilmaier, C., de Greiff, A., VOGT, F. M., Ladd, M. E., Barkhausen, J., & Quick, H. H. (2010) · Academic Radiology · doi:10.1016/j.acra.2010.08.009 · Cited by 3
Nanopharmacology
Aguilar, Z. P. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385089-8.00007-8 · Cited by 3

Authors: Bremerich, J., Bilecen, D., & Reimer, P.
Affiliations: University Hospital of Basel (CH)
Städtisches Klinikum Karlsruhe (DE)
Corresponding author: Bremerich, Jens
ORCID: Bremerich, Jens
Bilecen, Deniz
Reimer, Peter
Venue: European Radiology
Publisher: Springer Science and Business Media LLC
Published: 2007-07-17
Volume: 17
Issue: 12
Pages: 3017-3024
ISSN: 0938-7994 (ISSN-L)
1432-1084
DOI: 10.1007/s00330-007-0712-0
OpenAlex: W2032850755
Cited by: 139
References: 43
Citations by year: 2024: 5 · 2022: 5 · 2021: 6 · 2020: 7 · 2019: 4 · 2018: 2 · 2017: 11 · 2016: 14 · 2015: 5 · 2014: 16 · 2013: 7 · 2012: 7
FWCI: 1.61
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: European Radiology (publishedVersion)
PubMed (publishedVersion)
reroDoc Digital Library (submittedVersion)
Topics: Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
Physical Sciences › Materials Science › Materials Chemistry › Lanthanide and Transition Metal Complexes
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
Keywords: blood pool contrast agent, contrast-enhanced MR angiography, gadofosveset, ultrasmall superparamagnetic iron oxide, gadolinium-based contrast agents, serum albumin binding, relaxivity, carotid angiography, renal angiography, peripheral angiography
MeSH terms: Contrast Media, Dextrans, Gadolinium, Humans, Iron, Organometallic Compounds, Oxides, Vascular Diseases, Magnetic Resonance Angiography, Ferrosoferric Oxide, Magnetite Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

MR angiography with blood pool contrast agents

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks